Continuous use of closed-loop system increases time in range, decreases hypoglycemia
4/15/2016
Results from one of the CDT's recent studies showed that by using closed-loop control 24/7 median time at less than 70 mg/dL decreased from 4.1% at baseline to 1.7% (P…
Marc Breton Describes Artificial Pancreas Components – YouTube
4/15/2016
In the video below, UVA engineer Marc Breton describes the current state of the CDT's artificial pancreas algorithms!
To Test Artificial Pancreas, Kids With Diabetes Hit The Slopes | CPR
4/14/2016
The study's final results won't be ready for awhile but initial findings were positive," said Dr. Greg Forlenza of CU-Denver Source: To Test Artificial Pancreas, Kids With Diabetes Hit…
4/11/2016
A trial using UVA's artificial pancreas software in France is discussed starting minute 15 of the linked video: Le journal de 13h - Le 13 heures du 7 avril 2016.…
Kids With Diabetes Hit Slopes To Test Artificial Pancreas System
4/6/2016
We are [...] testing some innovative technologies that ultimately are going to benefit all people with type 1 diabetes to make their life a little bit more about living and…
Artificial pancreas could be ready in 2017 for diabetics
3/30/2016
The algorithms it is based on are resulting in better and better outcomes. For people with type I diabetes, it's quite a hopeful time." -Dr. Marc Breton Source: Artificial pancreas…
Artificial pancreas: game changer for diabetes treatment? – Medical News Today
2/20/2016
The idea of an artificial pancreas has been discussed for decades, but it is only very recently that it has become a potentially viable option.Designed by Boris Kovatchev and his…
Funding Secured for Artificial Pancreas Trials
1/11/2016
The National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health has awarded the Center for Diabetes Technology, led by researcher Dr. Boris Kovatchev, $12.7 million dollars for two finalizing trials of the Artificial Pancreas.
4/1/2012
Follow Dia-Beat This as she blogs about her experience in an Artificial Pancreas trial.
